Annual report 2023/24

Patents

The Fraunhofer IZI patent portfolio currently consists of 56 patent families (excluding patents held at Fraunhofer IZI-BB), which are available for use in collaborative projects as well as for direct marketing and licensing.

• Novel delivery systems for nucleic acids
• Methods for the diagnosis of infectious agents
• Methods for the diagnosis of cancer
• New treatment methods for cancer and other diseases 
• New method for the prevention of graft-versus-host disease (GvHD) 
• Method for immobilization of cells on surfaces 
• Mineral compounds for prevention / therapy of kidney and intestinal diseases
• Method for the preparation of a leukocyte preparation 
• Biomarkers and diagnostic systems for human or veterinary application 
• RNA species for therapeutic and / or diagnostic use 
• Methods and devices for point-of-care diagnostics
• Agents for the therapy of infectious as well as fibrotic and neurodegenerative diseases
• New viral vectors for the gene modification of immune cells
• Surface modification
• Inactivation of pathogens in the context of vaccine production and novel vaccine candidates
• Novel ATMPs and methods for their optimization
• Epitopes from food relevant for the development of allergies and methods for allergen extraction
• Technologies for microfluidic systems
• Dialysis methods and novel components of dialysis systems
• Novel AAV vectors